entertainment -WSS

entertainment

author：explore 2025-08-12 08:28:35 - browse：79

A masked person wears Onward Medical’s non-invasive spinal cord stimulator, solving a Rubik's cube — health tech coverage from STAT — Courtesy Onward Medical

After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat.

So when Campbell started sweating on his stationary bike for the first time in seven years, it felt surreal. It was late 2021, and Campbell was nearing the end of a clinical trial testing out a device to help paralyzed patients regain movement.

“I felt really refreshed and excited, because you get to this point where normally I’d have to back off or monitor if I’m overheating,” Campbell, 41, said. “To break through that, it just feels clear.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Gene editing the human germline: What are the risks?

WSS

The a glaring gap in research on serious mental illness and primary care

Colonoscopy prep: Liquid

Alnylam reports growth in sales of rare disease treatments

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Virtual Event: March of the Biosimilars

U.K. researchers warn about biases in medical devices, algorithms

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Plastic surgeons increase patient psychiatric screenings

Sports medicine is finally prioritizing gender equality

Pharma showers House GOP doctor with campaign cash

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Methadone treatment changes are coming. Do they go far enough?

Bright Health sells Medicare Advantage business to Molina

Stop the failed accountable care organization experiment

How one medical school became remarkably diverse

FDA approves Sage Therapeutics’ rapid

leisure time

SCOTUS questions limit to govt efforts to fight misinformation

AstraZeneca to buy developer of next

Late stage cancers on the rise after pandemic delayed screenings

Study links childhood stress with decline in older age

Physicians aren't 'burning out.' They're suffering from moral injury

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

explore

Wikipedia

hotspot

focus